ArticleHaematologica2021
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia.
Christoph Kornauth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it
ArticleHaematologica2021
Christoph Kornauth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.